about
Possible functions of CD169-positive sinus macrophages in lymph nodes in anti-tumor immune responsesReconciling evidence-based medicine and precision medicine in the era of big data: challenges and opportunitiesElevated frequencies of CD8 T cells expressing PD-1, CTLA-4 and Tim-3 within tumour from perineural squamous cell carcinoma patients.Neutrophils in the tumor microenvironment: trying to heal the wound that cannot heal.Applying Precision Medicine and Immunotherapy Advances from Oncology to Host-Directed Therapies for Infectious DiseasesImmunoproteasomes and immunotherapy-a smoking gun for lung cancer?Altered Expression of Natural Cytotoxicity Receptors and NKG2D on Peripheral Blood NK Cell Subsets in Breast Cancer Patients.Tumor-infiltrating lymphocyte composition, organization and PD-1/ PD-L1 expression are linked in breast cancer.Colorectal Cancer Liver Metastasis: Evolving Paradigms and Future Directions.Structural basis of a novel PD-L1 nanobody for immune checkpoint blockade.Physiologically activated mammary fibroblasts promote postpartum mammary cancerQuantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis.Opportunities and challenges in the immunological therapy of pediatric malignancy: a concise snapshot.Immunotherapeutic strategies in non-small-cell lung cancer: the present and the future.Development and characterization of naive single-type tumor antigen-specific CD8+ T lymphocytes from murine pluripotent stem cells.Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade.Selective Blockade of the Ubiquitous Checkpoint Receptor CD47 Is Enabled by Dual-Targeting Bispecific Antibodies.CXCL13-producing TFH cells link immune suppression and adaptive memory in human breast cancerThe roles of tumor- and metastasis-promoting carcinoma-associated fibroblasts in human carcinomas.Emerging links among Chromosome Instability (CIN), cancer, and aging.Mouse models in oncoimmunology.Cytokine profiling of tumor interstitial fluid of the breast and its relationship with lymphocyte infiltration and clinicopathological characteristics.Crystal clear: visualizing the intervention mechanism of the PD-1/PD-L1 interaction by two cancer therapeutic monoclonal antibodies.TILs in Head and Neck Cancer: Ready for Clinical Implementation and Why (Not)?Determinants of metastatic competency in colorectal cancer.Concise Review: An (Im)Penetrable Shield: How the Tumor Microenvironment Protects Cancer Stem Cells.Insights into mortality patterns and causes of death through a process point of view model.Role of AHR and HIF-1α in Glioblastoma Metabolism.Tuning cancer fate: the unremitting role of host immunity.Tumor-associated fibrosis as a regulator of tumor immunity and response to immunotherapy.A Primer for Oncoimmunology (Immunooncology).The peritoneum: healing, immunity, and diseases.Nutrition, inflammation and cancer.The immune contexture in cancer prognosis and treatment.In vitro effects of Staphylococcus aureus enterotoxin C3 on T cell activation, proliferation and cytokine production.Artificial human antigen-presenting cells are superior to dendritic cells at inducing cytotoxic T-cell responses.Open-label Phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L.Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy.Cancer therapy in a microbial bottle: Uncorking the novel biology of the protozoan Toxoplasma gondii.Clinical significance of tumor-infiltrating lymphocytes for gastric cancer in the era of immunology
P2860
Q28068802-154704E5-B49B-42C0-A5A7-0BB28A49B8A9Q28586368-93595B6D-E952-413D-8405-6531A72E9F77Q33579474-7DA98DCB-D3AC-45F1-9D81-62CD68D4B0E0Q33816141-2EF72DA9-0B5F-4823-88C4-1B1302D7A72CQ33849778-E2E58A25-91C1-47B5-9427-B9022CF154D4Q37121401-E546B31B-9366-424F-B757-EF9439962D47Q37257918-A503174E-BFCF-4FCF-825C-C05782EDF953Q37616487-26A921F6-29AD-4B6A-8CB0-0686692CB5F6Q37673704-66AD0205-293D-4656-9661-542D88D6A8DBQ37686620-FE9B433A-2FBB-4DEC-BD08-663983803CC3Q37711835-EF250BB2-0F02-443F-8AAE-E5A0C289D054Q38375185-E1ED621C-9B5D-4683-8F7E-A4752A54A609Q38643300-60D3EA99-886E-4994-A670-A1C24D1F654CQ38687631-EA42E4A9-39D9-41F5-ABAF-D8D60A31C051Q38694821-4D890397-7599-4696-BF1A-C3AE3B2CE830Q38707904-224AD1B6-5B46-43E5-9034-22A3DA9CEDE6Q38718295-134F0A2A-F09C-40AA-B28B-286AA22F1FD8Q38751056-C7020F6E-EF1A-4DBF-B94F-6E12F0EC5303Q38922999-77393E06-13B7-46D1-8BF5-0BBD5E7E16B3Q38929880-DA8129A8-78C5-4C50-B0F0-0417A8F56DBDQ38968582-D97FDCA6-3769-4640-8FF1-B36B7EAC8B37Q38998423-39D9831E-08B9-4098-A046-6AFC4F68A83FQ38999322-98C5B239-D080-4EAD-9438-745BC59518B8Q39055075-28608DF4-937C-43B0-A154-0FB72793D8E1Q39085740-52A234C2-C5DD-4DC5-9280-CA8BF457563EQ39138664-3C61CACF-C1A1-4845-B470-5DBB2530955BQ39155178-181438BF-AEB6-4758-8077-086EBDE1FAEAQ39187735-35FA67D3-98FB-4A43-B4AA-04EF14729634Q39239026-EF3B070A-27BF-4A0B-98F5-FF163DBB19FEQ39268764-238C37D2-E952-4AB9-B947-756E29399D01Q39387761-4E928C71-1830-4E3B-9AC6-0C1F1195D2B8Q39443675-1A5C04DB-8C2C-4B64-9324-31BCB622B980Q39443978-DA52F8F5-C251-46FB-B479-0B4D430A93E1Q39456999-A94EB0A3-52A4-445F-9EE7-7E107D861A63Q40076515-47793A4C-56DB-494E-8976-9979AFF65151Q40140002-84E6C726-540A-4A00-9936-D5C1B99275E4Q40227841-0858F16D-860F-4478-8FA1-0F65B62B4FDBQ40302175-898DED87-1666-48B3-8274-C9C71A9858DEQ41068755-393ED894-2A51-4C08-B74A-025ADB4066A3Q41169821-366B0A68-A868-4312-AD1D-67A4668B899E
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The Basis of Oncoimmunology
@ast
The Basis of Oncoimmunology
@en
type
label
The Basis of Oncoimmunology
@ast
The Basis of Oncoimmunology
@en
prefLabel
The Basis of Oncoimmunology
@ast
The Basis of Oncoimmunology
@en
P2860
P1433
P1476
The Basis of Oncoimmunology
@en
P2093
A Karolina Palucka
Lisa M Coussens
P2860
P304
P356
10.1016/J.CELL.2016.01.049
P407
P577
2016-03-01T00:00:00Z